|
|||||
Internal Medicine - Gastroenterology |
|||||
|
Internal Medicine
Division of
Digestive Diseases and Nutrition CONTACT
|
Steven Shedlofsky, M.D.
Board Certifications Internal Medicine, American Board of Internal Medicine, 1977 Clinical Interests and ExpertiseHepatitis: Hepatitis B, fatty liver, hepatitis C, liver transplantation Research Interests Basic mechanisms of injury in hepatitis C Representative PublicationsShedlofsky S.I., Israel B.C., McClain C. J., Hill D.B., Blouin R.A.: Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 94:2209-2214, 1994. Shedlofsky S.I. , Israel B.C., Tosheva R., Blouin R.A.: Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women. Brit J Clin Pharmacol 43:627-632, 1997. Sinclair P.R., Gorman N., Shedlofsky S.I., Honsinger C.P., Sinclair J.F., Karagas M.R., Anderson K.E.: Ascorbic acid deficiency in porphyria cutanea tarda. J Lab Clin Med 130:197-201, 1997. Roe A.L., Warren G., Hou G., Howard G., Shedlofsky S.I., Blouin R.A.: The effect of high dose endotoxin on CYP3A2 expression in the rat. Pharmaceut Res 15:1607-12, 1998. Stoeckel K., Hofheinz W., Laneury J .P., Duchene P., Shedlofsky S., Blouin R.: Stability of cephalosporin prodrug esters in human intestinal juice: implications for oral bioavailability. Antimicrob Agents Chemother 42:2602-2606, 1998. Watson A.M., Warren G., Howard G., Shedlofsky S.I., Blouin R.A.: Activities of conjugating and antioxidant enzymes following endotoxin exposure. JBiochem Mol Toxicol 13:63-69, 1999. Poloyac S.M., Tosheva R.T., Gardner B.M., Shedlofsky S.I., Blouin, R.A.: The effect of endotoxin administration on pharmacokinetics of chlorzoxazone in humans. Clin Pharmacol Ther 66:554-62, 1999. Shedlofsky S.I., Tosheva R.T., Snawder J.A.: Depression of constitutive murine cytochromes P450 by staphylococcal enterotoxin B. Biochem Pharmacol 59:1295-1303, 2000. Roe A.L., Poloyac S.M., Howard G., Shedlofsky S.I., Blouin R.A.: The effect of endotoxin on hepatocyte nuclear protein binding: potential implications on CYP2E1 expression in the rat. JPharm Pharmacol 53:1365-1371, 2001. Rockich K., Tosheva R., Cunningham C., Goeger D., Blouin R., Shedlofsky S.: The effects of endotoxin administration on three putative CYP3A markers in human subjects. (submitted) |
| Comments and Corrections | An Equal Opportunity University | Jobs | Terms, Conditions and Accessibility Statements | Privacy | |
|
© 2012, University of Kentucky College of Medicine, 138 Leader Ave., Lexington, Kentucky, USA 40506-9983
Student Affairs: (859) 323-5261 · Admissions: (859) 323-6161 · Clinical Questions: (859) 257-1000 · Dean's Office: (859) 323-6582 Page last updated Thursday, April 04, 2013 |
|